Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth
AssigneeCedara-Sinai Medical Center
InventorsHenry C. Lin, Mark Pimentel
Life of this patent
Estimating the term…
Loading patent…
AssigneeCedara-Sinai Medical Center
InventorsHenry C. Lin, Mark Pimentel
Estimating the term…
Disclosed is a method of diagnosing irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, or Crohn's disease, which involves detecting the presence of small intestinal bacterial overgrowth (SIBO) in a human subject having at least one symptom associated with a suspected diagnosis of any of those diagnostic categories. Also disclosed is a method of treating these disorders, and other disorders caused by SIBO, that involves at least partially eradicating a SIBO condition in the human subject. The method includes administration of anti-microbial or probiotic agents, or normalizing intestinal motility by employing a prokinetic agent. The method improves symptoms, including hyperalgesia related to SIBO and disorders caused by SIBO. Also disclosed is a kit for the diagnosis or treatment of irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, or Crohn's disease.
A method of treating bloating in a subject, comprising:
A method of treating bloating in a subject suffering from small intestinal bacterial overgrowth, comprising administering rifaximin to the subject in an amount sufficient to at least partially eradicate the small intestinal bacterial overgrowth.
Dependencies are inferred from the claim text.